Mekophar Chemical Pharmaceutical JSC

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: VN000000MKP6
VND
27,200.00
100 (0.37%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'11
Dec'10
Net Sales
9,19,577.45
9,04,746.57
10,44,754.70
8,94,740.90
Other Operating Income
0.00
0.00
0.00
0.00
Total Operating income
9,19,577.45
9,04,746.57
10,44,754.70
8,94,740.90
Raw Material Cost
6,84,386.32
6,50,541.20
8,48,524.85
7,09,645.32
Purchase of Finished goods
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
Employee Cost
1,23,662.78
1,34,618.61
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
500.88
0.00
0.00
Selling and Distribution Expenses
2,18,295.12
2,19,577.16
99,853.12
96,279.37
Other Expenses
-12,366.28
-13,511.95
0.00
0.00
Total Expenditure (Excl Depreciation)
9,02,681.43
8,70,118.36
9,48,377.97
8,05,924.68
Operating Profit (PBDIT) excl Other Income
16896
34628.200000000004
96376.7
88816.20000000001
Other Income
61,717.51
19,402.86
4,547.24
3,741.34
Operating Profit (PBDIT)
1,00,599.55
74,944.96
1,17,948.70
1,07,958.41
Interest
0.00
500.88
0.00
0.00
Exceptional Items
0.00
17,366.83
0.00
0.00
Gross Profit (PBDT)
2,35,191.14
2,54,205.37
1,96,229.84
1,85,095.58
Depreciation
47,464.76
48,496.58
17,024.74
15,400.85
Profit Before Tax
53,134.79
43,314.33
1,00,923.97
92,557.56
Tax
12,349.54
18,200.20
23,952.84
21,543.55
Provisions and contingencies
0.00
0.00
0.00
0.00
Profit After Tax
40,785.25
21,161.15
76,971.13
71,014.02
Extraordinary Items
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
Net Profit
40,785.25
21,161.15
76,971.13
71,014.02
Share in Profit of Associates
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
Consolidated Net Profit
40,785.25
21,161.15
76,971.13
71,014.02
Equity Capital
0.00
0.00
0.00
0.00
Face Value
10000.0
10000.0
10000.0
10000.0
Reserves
12,84,684.01
12,60,893.85
4,09,443.44
3,73,035.63
Earnings per share (EPS)
1614.09
837.46
0.0
0.0
Diluted Earnings per share
1614.09
837.46
0.0
0.0
Operating Profit Margin (Excl OI)
-0.93%
0.78%
9.22%
9.93%
Gross Profit Margin
10.94%
10.15%
11.29%
12.07%
PAT Margin
4.44%
2.34%
7.37%
7.94%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 1.64%

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 92.74%

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is -30.00%

stock-summary

Interest

YoY Growth in year ended Dec 2024 is -100.00%

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has fallen from Dec 2023

Compare Annual Results Of Mekophar Chemical Pharmaceutical JSC With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(VND)
Change(%)
Net Sales
9,19,577.45
4,43,135.81
4,76,441.64
107.52%
Other Operating Income
0.00
0.00
0.00
Total Operating income
9,19,577.45
4,43,135.81
4,76,441.64
107.52%
Raw Material Cost
6,84,386.32
3,52,813.24
3,31,573.08
93.98%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
1,23,662.78
0.00
1,23,662.78
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
2,417.35
-2,417.35
-100.00%
Selling and Distribution Expenses
2,18,295.12
68,209.31
1,50,085.81
220.04%
Other Expenses
-12,366.28
-241.73
-12,124.55
-5,015.74%
Total Expenditure (Excl Depreciation)
9,02,681.43
4,21,022.55
4,81,658.88
114.40%
Operating Profit (PBDIT) excl Other Income
16,896.02
22,113.26
-5,217.24
-23.59%
Other Income
61,717.51
-358.00
62,075.51
17,339.53%
Operating Profit (PBDIT)
1,00,599.55
29,516.68
71,082.87
240.82%
Interest
0.00
2,417.35
-2,417.35
-100.00%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
2,35,191.14
90,322.57
1,44,868.57
160.39%
Depreciation
47,464.76
7,761.42
39,703.34
511.55%
Profit Before Tax
53,134.79
19,337.92
33,796.87
174.77%
Tax
12,349.54
4,155.30
8,194.24
197.20%
Provisions and contingencies
0
0
0.00
Profit After Tax
40,785.25
15,182.61
25,602.64
168.63%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
40,785.25
15,182.61
25,602.64
168.63%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
40,785.25
15,182.61
25,602.64
168.63%
Equity Capital
0
0
0.00
Face Value
10,000.00
10,000.00
0.00
Reserves
12,84,684.01
3,30,799.03
9,53,884.98
288.36%
Earnings per share (EPS)
1,614.09
1.22
1,612.87
132,202.46%
Diluted Earnings per share
1,614.09
1.22
1,612.87
132,202.46%
Operating Profit Margin (Excl OI)
-0.93%
4.99%
0.00
-5.92%
Gross Profit Margin
10.94%
6.12%
0.00
4.82%
PAT Margin
4.44%
3.43%
0.00
1.01%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 91,957.75 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 1.64%

Annual - Consolidate Net Profit
Consolidate Net Profit 4,078.53 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 92.74%

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 3,888.20 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -30.00%

Annual - Interest
Markets Mojo
No Interest in the last few periods
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -0.93%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has fallen from Dec 2023